Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer

Pancreas

Volumn 21, Issue 3, 2000, Pages 240-247

  Lu, Zhao ^a   Kleeff, Jörg ^a   Shrikhande, Shailesh ^a   Zimmermann, Arthur ^b   Korc, Murray ^c   Friess, Helmut ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemotherapy; Multidrug resistance; P glycoprotein; Pancreatic cancer

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL;

ADULT; AGED; BLOTTING, NORTHERN; FEMALE; GENE EXPRESSION; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PANCREATIC NEOPLASMS; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE;

EID: 0033803167     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200010000-00004     Document Type: Article

References (28)

1. Cancer statistics 1997
2. A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody) in resectable pancreatic cancer
3. Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin
4. P-glycoproteins: Mediators of multidrug resistance
5. MDR1 gene expression: Evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas
6. MDR1 gene expression in solid tumors
7. Clinical significance of multiple drug resistance in human cancers
8. Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: Relevance to indicator of better prognosis
9. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression
10. Kail expression is upregulated in early pancreatic cancer and decreased in the presence of metastases
11. Restricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes
12. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha
13. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes
14. Increased expression of transforming growth factor betas after acute oedematous pancreatitis in rats suggests a role in pancreatic repair
15. Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer
16. Clinical correlations of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas
17. MDR 1 levels in human renal cell carcinomas: Correlation with grade and prediction of doxorubicin resistance by quinidine in tumor explants
18. Expression of mdr1/p-glycoprotein and p110 in neuroblastoma
19. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas
20. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy and disease relapse
21. Prognostic value of protein kinase c, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia
22. Multidrug resistance gene expression in childhood medulloblastoma: Correlation with clinical outcome and DNA ploidy in 29 patients
23. Distribution of multidrug resistance associated P-glycoprotein in normal and neoplastic human tissues
24. P-glycoprotein expression as a predictor of breast cancer recurrence
25. Immunocytochemical detection of P-glycoprotein: Initial expression correlates with survival in renal cell carcinoma patients
26. Expression of P-glycoprotein in hepatocellular carcinoma: A potential marker of prognosis
27. P-glycoprotein expression during tumor progression in the rat liver